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In recent years right ventricular septal pacing (RVSP) has been performed instead of right
ventricular apical pacing (RVAP) because of the detrimental eﬀects on the ventricular
function associated with the latter type of pacing. However, little information has been
available on the comparison of the cardiac function between RVAP and RVSP in individual
patients. Therefore, we compared the changes in the cardiac index (CI) between RVAP and
RVSP (right ventricular outﬂow tract or mid-ventricular tract) in each patient in whom a
permanent pacemaker was implanted. We measured both the QRS duration and acute phase of
the cardiac function by means of a Swan-Ganz catheter and compared the results between
RVAP and RVSP. RVSP was associated with a shorter QRS duration (139:5 4:6 vs.
180:6 4:6msec, p < 0:0001) in comparison to RVAP. Although there was no signiﬁcant
diﬀerence in the CI between the 2 pacing positions (2:71 0:12 vs. 2:74 0:13L/min/m2,
p ¼ 0:6969), the CI among the patients with complete atrioventricular block (cAVB) had a
strong tendency of being better with RVSP patients (2:65 0:19 vs. 2:84 0:19L/min/m2,
p ¼ 0:1444). It is suggested that the beneﬁcial eﬀect of RVSP diﬀers according to the causal
disorder for pacemaker implantation.
(J Arrhythmia 2009; 25: 70–76)
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Introduction
The implantation of permanent pacemakers has
become an established technique for treating bra-
dyarrhythmias such as sick sinus syndrome (SSS) or
atrioventricular block (AVB) over the last several
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decades. With this technique, right ventricular apical
pacing (RVAP) is a common methodology to
preserve a desirable heart rate. However, several
studies have shown that RVAP may bring about
an inappropriate ventricular function during long
term observation.1–5) To avoid this disadvantage
of RVAP, right ventricular septal pacing (RVSP)
has been highlighted as a new ventricular pacing
method.6–8) Most investigations have targeted the
comparison of the cardiac function between the
patient groups with RVAP and RVSP. However,
there is little information on the diﬀerence in the
cardiac function between the two pacing sites in the
same individuals.9,10)
To elucidate this diﬀerence, we compared the
change in the cardiac index (CI) between RVAP and
RVSP immediately before the permanent pacemaker
implantation procedure in the patients with bradyar-
rhythmias. Here RVSP means pacing in the outﬂow
tract (RVOT) or mid-ventricular tract of the right
ventricular septal aspect (RVMS).
Patients and Methods
Patient recruitment began August 9, 2007, and
ended June 22, 2008, and 21 patients were enrolled.
Patient characteristics are shown in Table 1. In each
patient, a pacing lead was initially positioned in the
right atrial appendage. The ventricular lead was
initially positioned in the RVA, and later moved to
the RVOT or RVMS. Each ventricular lead site
placement was determined by means of the 12-lead
Table 1 Patient data (n ¼ 21)
Age 75.0  1.3
EF (%) 63.1  2.1
BNP (pg/ml) 357.3  114.3
Gender Male Female
SSS 2 5
AF with bradycardia 1 1
Advanced AVB 6 0
Complete AVB 3 3
Total 12 9
Concurrent disease HT 11, DM 5, HLp 7, AP 1, OMI 1, CHF 1,
CRnF 4, Regular HD 2, Collagen disease 1,
None 4,
(mean S.E)
RVAP RVOT RVMS
Figure 1 Typical electrocardiographic appearance at each pacing site
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surface electrocardiogram (ECG) (Figure 1), and
ﬂuoroscopic radiographs (Figure 2). The order of
ventricular pacing lead positioning was switched
randomly case by case. In both positions, DDD
pacing was utilized except in the case of atrial
ﬁbrillation (AF). Though the pacing rate and AV
delay diﬀered among patients according to the P rate
and PQ duration, the same pacing rate and AV delay
were seen in each patient. The paced QRS duration
was obtained from the ECG, especially in lead II.
A) RVAP and RVMS
RVAP
RVMS 
Figure 2-A 30 right anterior oblique and 50 left anterior
oblique radiographic views of each lead position
A) RVAP and RVMS
B) RVAP and RVOT
RVAP 
RVOT
Figure 2-B 30 right anterior oblique and 50 left
anterior oblique radiographic views of each lead position
B) RVAP and RVOT
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After pacing for ﬁve minutes, the CI was measured
ﬁve times by means of a thermodilution method with
a Swan-Ganz catheter (Table 2), and the average of
three CIs, excluding the upper and lower CI, was
calculated. Finally, all patients received an implan-
tation of a permanent pacemaker with a ventricular
pacing site in the RVOT or RVMS. All statistics
were calculated by means of a paired t-test. This
study was approved by all patients who participated
in the study, and informed consent was obtained
from all patients.
Results
Twenty-one patients were included in the analysis
(Table 1). Each hemodynamic parameter exhibited
no signiﬁcant diﬀerence between the pacing posi-
tions (Table 3). RVSP was associated with a signiﬁ-
cantly shorter QRS duration in comparison with
RVAP (139:5 4:6 vs. 180:6 4:6msec, p <
0:0001) (Figure 3). There was no signiﬁcant diﬀer-
ence in the CI between RVAP and RVSP
(2:71 0:12 vs. 2:74 0:13L/min/m2, p ¼
0:6969) (Figure 4). According to the causal disease
for the permanent pacemaker implantation, the
complete AVB (cAVB) patient group (n ¼ 6) ex-
hibited a tendency toward an increased CI with the
RVSP rather than with the RVAP (2:84 0:19 vs.
2:65 0:19L/min/m2, p ¼ 0:1444), whereas the
Table 2 Patient data (n ¼ 21)
Gender Age Diag. PreEF (%)
Pre
BNP
(pg/ml)
RVAP
CI (L/min/M2)
RVSP
CI (L/min/M2)
Apex
QRS
(msec)
Septal
QRS
(msec)
F 72 SSS 51.1 1580 2.17 2.14 162 150
M 81 SSS 69.9 850 2.12 2.51 140 70
F 76 SSS 75.2 189 2.03 2.07 160 125
F 73 SSS 74 65.2 3.39 2.99 177 140
F 72 SSS 72.8 11.4 3.14 2.46 165 147
F 89 SSS 68 31.9 2.33 2.27 140 137
M 66 SSS 53.9 70.5 2.66 2.93 167 142
F 73 AF 54.8 106 2.27 1.85 190 175
M 76 AF 58.4 857 2.25 2.32 195 137
M 66 aAVB 73.9 82.3 3.44 3.19 220 147
M 77 aAVB 65.6 24.3 4.09 4.4 202 152
M 73 aAVB 55 68 3.06 2.9 185 157
M 76 aAVB 65.2 192 2.15 2.27 195 165
M 66 aAVB 64.5 13.8 2.85 2.95 180 152
M 81 aAVB 60.5 252 3.14 3.22 175 130
F 63 cAVB 63.6 368 2.99 3.04 177 152
F 76 cAVB 66.9 218 3.05 3.39 185 140
M 80 cAVB 67.8 243 2.56 3.14 187 115
M 79 cAVB 63.2 67.9 2.2 2.2 172 125
F 81 cAVB 40.8 1760 2.02 2.38 200 127
M 80 cAVB 65.5 314 3.06 2.9 220 145
Table 3 Hemodynamic parameters (mmHg, n ¼ 21)
RVAP RVSP P value
Systolic PAP 27.4  1.9 27.2  1.6 0.8172
Diastolic PAP 12.3  1.2 12.1  0.9 0.8297
Mean PAP 18.7  1.3 18.1  1.2 0.4808
PCWP 8.9  1.1 8.6  1.1 0.5867
Systolic RVP 28.3  1.8 29.0  1.7 0.5764
Diastolic RVP 2.8  0.6 3.6  0.6 0.1835
RVEDP 5.4  0.7 6.0  0.7 0.4210
Mean RAP 4.4  0.5 4.5  0.6 0.7603
HR 83.0  2.0 83.0  2.0 —
(mean S.E)
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SSS (n ¼ 7) and advanced AVB (aAVB) patient
groups (n ¼ 6) showed no signiﬁcant diﬀerence
(Figure 4). When the patients were divided into
groups according to degree of reduction in the QRS
duration of more than 37msec or less than 36msec
with the RVSP, the former patient group showed a
tendency toward having a higher CI during RVSP
than RVAP (2:97 0:19 vs. 2:85 0:20L/min/m2,
p ¼ 0:2213) whereas the latter exhibited no change
or had rather a lower CI during RVSP (2:49 0:14
vs. 2:56 0:13L/min/m2, p ¼ 0:4088) (Figure 5).
When the patients were divided into groups
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Figure 3 QRS duration (msec)
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Figure 4 CI (L/min/m2)
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according to a QRS duration of under 140msec or
over 141msec during RVSP, the former exhibited
a higher CI during RVSP than during RVAP
(2:65 0:15 vs. 2:51 0:16L/min/m2, p ¼
0:1505), whereas the latter exhibited a lower CI
during RVSP than RVAP (2:82 0:20 vs.
2:90 0:18L/min/m2, p ¼ 0:4088) (Figure 6).
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Figure 5 Reduction in the QRS duration
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Figure 6 QRS duration during RVSP
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Discussion
The main ﬁnding in this study was that there was
no signiﬁcant diﬀerence in the CI of the acute phase
between the RVSP and RVAP in any of the patients;
however, the RVSP was associated with a signiﬁ-
cantly shorter QRS duration than the RVAP. This
result suggested that the RVSP provided only a small
advantage for the cardiac function in the patient
group with a relatively normal left ventricular
function. However, it was postulated that the
advantage of the RVSP could have been overt when
the background disorder of the patients was limited
to cAVB. An additional ﬁnding was that the degree
of the reduction in the QRS was deeply related to the
improvement in the cardiac function during the
RVSP pacing although the diﬀerence in the CI
was not statistically signiﬁcant. As it is possible to
observe the diminishment in the QRS duration with
RVSP during the pacemaker implantation procedure,
it can be a desirable parameter for predicting the
eﬀect of the RVSP. Though there must be many
other factors associated with the improvement in the
cardiac function depending on the ventricular pacing
site, one factor associated with RVSP providing
a better CI than RVAP is considered to be the
improvement in the dyssynchrony of the left ven-
tricular wall motion. Further study is needed to
adequately stratify the patients in order to utilize the
beneﬁcial eﬀects of RVSP.
Conclusions
In this acute phase study, it was suggested that the
tendency of the beneﬁcial eﬀects of RVSP is based
on the existence of atrioventricular conduction
disorder and the degree of reduction in the QRS
duration. Further investigation and a long term
observation will be needed to judge the beneﬁcial
eﬀects of RVSP in comparison to RVAP.
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